Valuation: Proteome Sciences plc

Market Cap 5.59M 7.62M 6.53M 6.11M 10.5M 730M 10.64M 72.2M 28.16M 366M 28.63M 28.01M 1.21B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 20.58M 28.05M 24.03M 22.49M 38.63M 2.68B 39.14M 266M 104M 1.35B 105M 103M 4.46B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 day-6.18%
1 week-11.63%
Current month-11.39%
1 month-16.05%
3 months+6.33%
6 months-20.65%
Current year-36.20%
1 week 1.42
Extreme 1.425
2.1
1 month 1.42
Extreme 1.425
2.2
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
15.02
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
6/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-6.18%-11.63%-48.55%-78.00% 7.62M
+2.19%+4.84%-11.64%+12.29% 202B
+1.14%+2.28%+2.47%+14.39% 119B
+1.06%+1.34%+4.88%+75.73% 60.69B
-1.37%-6.57%+28.86%+58.31% 52.38B
+2.33%+4.69%-2.35%-30.34% 52.3B
+2.35%+2.89%+14.54%-11.79% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+45.52%-10.08% 24.85B
-0.29%-3.87%-6.22%+24.74% 23.84B
Average +0.62%-0.91%+3.06%+6.14% 60.03B
Weighted average by Cap. +1.53%+1.90%+1.96%+17.87%

Financials

2024 2025
Net sales 4.89M 6.66M 5.71M 5.34M 9.17M 637M 9.29M 63.08M 24.6M 320M 25.01M 24.47M 1.06B 3.76M 5.12M 4.39M 4.1M 7.05M 490M 7.14M 48.48M 18.9M 246M 19.22M 18.8M 814M
Net income -3.41M -4.64M -3.98M -3.72M -6.39M -444M -6.48M -43.96M -17.14M -223M -17.43M -17.05M -738M -3.06M -4.17M -3.57M -3.34M -5.74M -399M -5.82M -39.51M -15.41M -201M -15.67M -15.33M -663M
Net Debt 13.39M 18.26M 15.64M 14.63M 25.14M 1.75B 25.47M 173M 67.42M 877M 68.55M 67.06M 2.9B 14.99M 20.43M 17.5M 16.37M 28.13M 1.95B 28.5M 193M 75.44M 982M 76.71M 75.04M 3.25B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
21/08/26 GBX 1.595 -6.18% 226,719
20/08/26 GBX 1.700 -5.29% 718,017
19/08/26 GBX 1.795 -0.28% 52,039
18/08/26 GBX 1.800 +0.28% 111,376
17/08/26 GBX 1.795 -0.55% 23,304